Top compounds associated with response to CTD-2021K4.1


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.038 0.3
mRNA ouabain CTRPv2 pan-cancer AAC 0.04 0.3
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC -0.041 0.3
mRNA BRD-K99006945 CTRPv2 pan-cancer AAC 0.064 0.3
mRNA BRD-K48477130 CTRPv2 pan-cancer AAC -0.068 0.3
mRNA BRD-K01737880 CTRPv2 pan-cancer AAC 0.14 0.3
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.042 0.3
mRNA BRD-K49290616 CTRPv2 pan-cancer AAC 0.079 0.3
mRNA skepinone-L CTRPv2 pan-cancer AAC -0.061 0.3
mRNA BRD-K79669418 CTRPv2 pan-cancer AAC -0.056 0.3
Download CSV